neo-checkray: boosting pcr rates in cold tumors
Published 1 month ago • 22 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:08
enhancing immunotherapy response in luminal b breast cancer with radiotherapy
-
0:54
neo-checkray: chemotherapy and sbrt with durvalumab and oleclumab in er /her2- breast cancer
-
0:53
neo-checkray: safety findings of radiotherapy and immunotherapy in breast cancer
-
1:59
effectiveness of icis in the neoadjuvant and post-neoadjuvant breast cancer setting
-
1:25
role of her2 expression and pcr in predicting early outcomes in her2-positive breast cancer
-
1:33
assessing the link between tils and pcr in the nsabp b-41 trial
-
1:30
phase i/ii trial of dendrimer-enhanced sn38 in patients with advanced solid tumors
-
4:11
personalized, neoantigen-directed immunotherapy in patients with advanced mss-crc, gea and nsclc
-
0:49
dr. o’regan on prognostic value of pcr in her2 breast cancer
-
1:07
heating up a tumor: modulating the immunoscore
-
45:10
cancer immunotherapy workshop 2021 – moderated open discussion: immune effects by tumor types
-
1:38
compassher2-pcr: de-escalation of neoadjuvant chemotherapy for breast cancer
-
1:36
defi: nirogacestat demonstrates improved pfs and orr in progressing desmoid tumors
-
7:26
i-spy 2: immunotherapy biomarkers in early breast cancer
-
34:31
netwise episode 4: nuclear medicine for nets: prrt- (see episode 28 for the updated version)
-
0:48
phase i/ii trial of adapt-001, an oncolytic virus, and a checkpoint inhibitor in solid tumors
-
0:35
recruitment criteria of the everest-2 trial assessing a2b694 in solid tumors
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
2:13
changes in tumour biomarkers after neoadjuvant chemotherapy in breast cancer